Home Healthcare Pharmaceuticals Pemetrexed Market

Pemetrexed Market Size, Share & Trends Analysis Report By Application (Malignant Pleural Mesothelioma, Non-Squamous NSCLC), By End-User (Hospitals, Oncology Centers, Online Pharmacies, Offline Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR206DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Pemetrexed Market Size Analysis
    1. Introduction
    2. Pemetrexed Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Malignant Pleural Mesothelioma
      2. Non-Squamous NSCLC
    3. Pemetrexed Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Oncology Centers
      3. Online Pharmacies
      4. Offline Pharmacies
  7. North America Pemetrexed Market Size Analysis
    1. Introduction
    2. Pemetrexed Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Malignant Pleural Mesothelioma
      2. Non-Squamous NSCLC
    3. Pemetrexed Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Oncology Centers
      3. Online Pharmacies
      4. Offline Pharmacies
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
  8. Europe Pemetrexed Market Size Analysis
    1. Introduction
    2. Pemetrexed Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Malignant Pleural Mesothelioma
      2. Non-Squamous NSCLC
    3. Pemetrexed Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Oncology Centers
      3. Online Pharmacies
      4. Offline Pharmacies
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    6. France
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
  9. APAC Pemetrexed Market Size Analysis
    1. Introduction
    2. Pemetrexed Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Malignant Pleural Mesothelioma
      2. Non-Squamous NSCLC
    3. Pemetrexed Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Oncology Centers
      3. Online Pharmacies
      4. Offline Pharmacies
    4. China
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    7. India
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
  10. Middle East and Africa Pemetrexed Market Size Analysis
    1. Introduction
    2. Pemetrexed Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Malignant Pleural Mesothelioma
      2. Non-Squamous NSCLC
    3. Pemetrexed Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Oncology Centers
      3. Online Pharmacies
      4. Offline Pharmacies
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
  11. LATAM Pemetrexed Market Size Analysis
    1. Introduction
    2. Pemetrexed Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Malignant Pleural Mesothelioma
      2. Non-Squamous NSCLC
    3. Pemetrexed Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Oncology Centers
      3. Online Pharmacies
      4. Offline Pharmacies
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Malignant Pleural Mesothelioma
        2. Non-Squamous NSCLC
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Oncology Centers
        3. Online Pharmacies
        4. Offline Pharmacies
  12. Competitive Landscape
    1. Pemetrexed Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Eli Lilly and Company
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Stada Arzneimittel AG
    3. Eagle Pharmaceuticals, Inc
    4. Fresenius Kabi USA
    5. Teva Pharmaceuticals USA Inc
    6. Biocon
    7. Pfizer Inc.
    8. Apotex Inc
    9. Dr. Reddys Laboratories Ltd
    10. Cadila Pharmaceuticals.
    11. Accord Healthcare
    12. Accure Labs Pvt. Ltd
    13. Shanghai Henlius Biotech, Inc.
    14. Janssen Global Services LLC
    15. Checkpoint Therapeutics, Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.